Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBPM_FORESEE2024: Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk in a Multi-ethnic European Population: an Observational Cohorts' Study

NCT06670677 is registered in ClinicalTrials.gov with Aktiia SA as lead sponsor.

NCT NCT06670677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06670677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBPM_FORESEE2024: Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk in a Multi-ethnic European Population: an Observational Cohorts' Study
Lead sponsor
Aktiia SA
Phase
Observational
Overall status
Recruiting
Start date
May 12, 2025
Completion date
May 31, 2035
Enrollment
15,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure check (hypertension screening), cardiovascular risk, hypertension